167 related articles for article (PubMed ID: 23229133)
1. Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: role of inhibitor of apoptosis proteins (IAPs) and caspases.
Cregan IL; Dharmarajan AM; Fox SA
Int J Oncol; 2013 Feb; 42(2):444-52. PubMed ID: 23229133
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma.
Kang Y; Ding M; Tian G; Guo H; Wan Y; Yao Z; Li B; Lin D
Oncol Rep; 2013 Jul; 30(1):313-9. PubMed ID: 23624653
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.
Vanbervliet-Defrance B; Delaunay T; Daunizeau T; Kepenekian V; Glehen O; Weber K; Estornes Y; Ziverec A; Djemal L; Delphin M; Lantuéjoul S; Passot G; Grégoire M; Micheau O; Blanquart C; Renno T; Fonteneau JF; Lebecque S; Mahtouk K
Cancer Lett; 2020 Mar; 472():29-39. PubMed ID: 31838086
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
[TBL] [Abstract][Full Text] [Related]
7. An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.
Linton A; Cheng YY; Griggs K; Schedlich L; Kirschner MB; Gattani S; Srikaran S; Chuan-Hao Kao S; McCaughan BC; Klebe S; van Zandwijk N; Reid G
Br J Cancer; 2014 Jan; 110(2):510-9. PubMed ID: 24327015
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C
Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644
[No Abstract] [Full Text] [Related]
10. Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.
Kaku Y; Nagaya H; Tsuchiya A; Kanno T; Gotoh A; Tanaka A; Shimizu T; Nakao S; Tabata C; Nakano T; Nishizaki T
Cancer Sci; 2014 Jul; 105(7):883-9. PubMed ID: 24754309
[TBL] [Abstract][Full Text] [Related]
11. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
12. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
13. Licochalcone A induces apoptosis in malignant pleural mesothelioma through downregulation of Sp1 and subsequent activation of mitochondria-related apoptotic pathway.
Kim KH; Yoon G; Cho JJ; Cho JH; Cho YS; Chae JI; Shim JH
Int J Oncol; 2015 Mar; 46(3):1385-92. PubMed ID: 25586190
[TBL] [Abstract][Full Text] [Related]
14. Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
Kim KH; Chae JI; Oh H; Cho JH; Lee RH; Yoon G; Cho SS; Cho YS; Lee MH; Liu K; Lee HJ; Shim JH
Oncol Rep; 2016 Jul; 36(1):117-24. PubMed ID: 27176604
[TBL] [Abstract][Full Text] [Related]
15. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
16. Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
Cregan S; Breslin M; Roche G; Wennstedt S; MacDonagh L; Albadri C; Gao Y; O'Byrne KJ; Cuffe S; Finn SP; Gray SG
Int J Oncol; 2017 Mar; 50(3):1044-1052. PubMed ID: 28197626
[TBL] [Abstract][Full Text] [Related]
17. Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.
Kopecka J; Salaroglio IC; Righi L; Libener R; Orecchia S; Grosso F; Milosevic V; Ananthanarayanan P; Ricci L; Capelletto E; Pradotto M; Napoli F; Di Maio M; Novello S; Rubinstein M; Scagliotti GV; Riganti C
Lung Cancer; 2018 Jun; 120():34-45. PubMed ID: 29748013
[TBL] [Abstract][Full Text] [Related]
18. Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma.
Kleinberg L; Lie AK; Flørenes VA; Nesland JM; Davidson B
Hum Pathol; 2007 Jul; 38(7):986-994. PubMed ID: 17350081
[TBL] [Abstract][Full Text] [Related]
19. p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
Hopkins-Donaldson S; Belyanskaya LL; Simões-Wüst AP; Sigrist B; Kurtz S; Zangemeister-Wittke U; Stahel R
Neoplasia; 2006 Jul; 8(7):551-9. PubMed ID: 16867217
[TBL] [Abstract][Full Text] [Related]
20. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.
Urso L; Cavallari I; Silic-Benussi M; Biasini L; Zago G; Calabrese F; Conte PF; Ciminale V; Pasello G
Oncotarget; 2017 Jul; 8(27):44232-44241. PubMed ID: 28562336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
